Pennsylvania Patent of the Month – June 2025
A new U.S. patent could revolutionize how we monitor and manage diabetes. SynchNeuro Inc. has been granted U.S. Patent No. 12318206, titled ‘Blood glucose states based on sensed brain activity’, introducing a groundbreaking method to estimate blood sugar levels using brain signals-potentially reducing the need for invasive finger-prick tests.
Monitoring blood sugar through the brain
The patented system uses non-invasive brainwave sensors to detect patterns associated with high, low, or stable glucose states. Instead of measuring blood sugar directly from bodily fluids, the invention decodes neural signals related to a person’s metabolic state. This could enable continuous glucose monitoring through wearable neurotechnology.
Helping patients stay ahead of symptoms
For people with diabetes, real-time awareness of blood sugar levels is critical. The system can alert users to potential episodes of hypoglycemia or hyperglycemia before physical symptoms appear. That early warning capability may allow for faster interventions, improving safety and quality of life.
Future of glucose management
This patent reflects growing interest in merging neuroscience with metabolic health. SynchNeuro Inc. ‘s innovation could lead to smarter, less intrusive ways of managing chronic conditions through brain-computer interfaces. As healthcare trends move toward precision and personalization, such tools may redefine how we approach glucose monitoring.
Implications for digital health and AI
The invention also supports integration with artificial intelligence platforms, which could learn from individual brain responses to improve accuracy over time. This aligns with ongoing R&D in personalized digital diagnostics.
Learn More:
Are you developing new or improved products, or thinking of applying for a patent? Did you know your research work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? To find out more, please check out our free online eligibility test.
Feel free to book a quick teleconference with one of R&D Tax specialists if you would like to learn more about R&D Tax Credit opportunities.
Who We Are:
Swanson Reed is one of the largest Specialist R&D Tax Credit advisory firm in the United States. With offices nationwide, we are one of the only firms globally to exclusively provide R&D Tax Credit consulting services to our clients. We have been exclusively providing R&D Tax Credit claim preparation and audit compliance solutions for over 30 years.
Swanson Reed’s Pennsylvania office provides R&D tax credit consulting and advisory services to Philadelphia, Pittsburgh, Allentown, Erie, Reading, Scranton, Bethlehem, Lancaster, Harrisburg, Altoona, York, State College, Wilkes Barre, Chester, Williamsport, Easton, Lebanon, Hazleton, New Castle, and Johnstown.
Swanson Reed hosts daily free webinars and provides free IRS CE and CPE credits for CPAs. For more information please click here or contact your usual Swanson Reed representative.
